» Articles » PMID: 15016323

A Case-control Study of Diet and Prostate Cancer in Japan: Possible Protective Effect of Traditional Japanese Diet

Overview
Journal Cancer Sci
Specialty Oncology
Date 2004 Mar 16
PMID 15016323
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The age-adjusted incidence of prostate cancer is low in Japan, and it has been suggested that the traditional Japanese diet, which includes many soy products, plays a preventive role against prostate cancer. We performed a case-control study on dietary factors and prostate cancer in order to assess the hypothesis that the traditional Japanese diet reduces the risk of prostate cancer. Four geographical areas (Ibaraki, Fukuoka, Nara, and Hokkaido) of Japan were selected for the survey. Average daily intake of food from 5 years before the diagnosis was measured by means of a semi-quantitative food frequency questionnaire. We studied 140 cases and 140 individually age ( +/- 5 years)-matched hospital controls for analysis. Estimates of age-adjusted odds ratios (ORs) and linear trends were calculated by conditional logistic regression models with adjustment for cigarette smoking and total energy intake as confounding factors. Consumption of fish, all soybean products, tofu (bean curds), and natto (fermented soybeans) was associated with decreased risk. ORs of the fourth vs. first quartile and 95% confidence intervals (95%CIs) were 0.45 (0.20-1.02) for fish, 0.53 (0.24-1.14) for all soybean products, 0.47 (0.20-1.08) for tofu, and 0.25 (0.05-1.24) for natto. Consumption of fish and natto showed significantly decreasing linear trends for risk (P < 0.05). Consumption of meat was significantly associated with increased risk (the OR of the second vs. first quartile was 2.19, 95%CI 1.00-4.81). Consumption of milk, fruits, all vegetables, green-yellow vegetables, and tomatoes showed no association. Our results provide support to the hypothesis that the traditional Japanese diet, which is rich in soybean products and fish, might be protective against prostate cancer.

Citing Articles

Association between soy products and prostate cancer: A systematic review and meta-analysis of observational studies.

Huang Y, Wang W, Jin J Investig Clin Urol. 2024; 65(6):540-550.

PMID: 39505513 PMC: 11543648. DOI: 10.4111/icu.20240186.


Soy Product Consumption and the Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

Wang C, Ding K, Xie X, Zhou J, Liu P, Wang S Nutrients. 2024; 16(7).

PMID: 38613019 PMC: 11013307. DOI: 10.3390/nu16070986.


NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review.

Gutierrez-Virgen J, Pina-Pozas M, Hernandez-Tobias E, Taja-Chayeb L, Lopez-Gonzalez M, Meraz-Rios M PLoS One. 2023; 18(4):e0283726.

PMID: 37023111 PMC: 10079069. DOI: 10.1371/journal.pone.0283726.


Dairy products and the risk of developing prostate cancer: A large-scale cohort study (JACC Study) in Japan.

Mikami K, Ozasa K, Miki T, Watanabe Y, Mori M, Kubo T Cancer Med. 2021; 10(20):7298-7307.

PMID: 34606688 PMC: 8525158. DOI: 10.1002/cam4.4233.


Dietary Factors and Prostate Cancer Development, Progression, and Reduction.

Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, Wlodarek D, Gromadzka-Ostrowska J Nutrients. 2021; 13(2).

PMID: 33546190 PMC: 7913227. DOI: 10.3390/nu13020496.


References
1.
Morton M, Arisaka O, Miyake N, Morgan L, Evans B . Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002; 132(10):3168-71. DOI: 10.1093/jn/131.10.3168. View

2.
Lyn-Cook B, Rogers T, Yan Y, Blann E, Kadlubar F, Hammons G . Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer. 2000; 35(1):80-6. DOI: 10.1207/S1532791480-86. View

3.
Ewings P, Bowie C . A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer. 1996; 74(4):661-6. PMC: 2074670. DOI: 10.1038/bjc.1996.418. View

4.
Fincham S, Hill G, Hanson J, Wijayasinghe C . Epidemiology of prostatic cancer: a case-control study. Prostate. 1990; 17(3):189-206. DOI: 10.1002/pros.2990170303. View

5.
Jatoi A, Ellison N, Burch P, Sloan J, Dakhil S, Novotny P . A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003; 97(6):1442-6. DOI: 10.1002/cncr.11200. View